Alimta

... Genetic Engineering News - The Leading Publication in Biotechnology BODY { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND: #ececec; PADDING-BOTTOM: 0px; MARGIN: 0px; FONT: 85% Arial, Helvetica, sans-serif; PADDING-TOP: 0px } Log in Register Now UPDATED 8/8/2005 7:30:00 AM EST Contact Us Mary Ann Liebert, Inc.

About GEN Home In The News Breaking News Sticky Ends Online Current Issue Point of View Legal Affairs Wall $treet BioBeat New Products On The Web Community Discussion Forum Meeting Calendar Classifieds View Listings Submit a Listing GEN•careers Bio•JobMart Resources Links Subscribe to GEN Reprints Advertise in GEN Planning Calendar Media Kit Mailing List Rental Partnership Opportunities Editorial Editorial Calendar Meet the GEN Editors Gen database of Biotech Firms Home » In The News » Breaking News Breaking News Email article to a colleague Printer friendly version Hana Biosciences, Inc.

Awarded $159,000 NIH Grant for Expanded Preclinical Development of Talotrexin in Combination Therapy Hana Biosciences, Inc.

(OTCBB: HNAB), a South-San Francisco based biopharmaceutical company focused on advancing cancer care, was awarded a $159,000 Small Business Innovation Research (SBIR) grant entitled "Development of PT-523 for the treatment of lung cancer" by the National Institutes of Health (NIH).

The award will enable Hana Biosciences to expand preclinical s...

Read more...